Eleonora Chines
Pavia, 27100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Can Artificial Intelligence Transform Early Warning for Antimicrobial-Resistant Outbreak Clones? Approaches, Gaps, and Opportunities: A Scoping Review.
Journal: Antibiotics (Basel, Switzerland)
Published: May 26, 2026
Next-Generation Target Discovery in ESKAPE Pathogens: An AI-Driven Framework from Omics-Based to Systems-Level Modeling and Clinical Translation.
Journal: Antibiotics (Basel, Switzerland)
Published: March 30, 2026
Albumin Nanoparticles Improve Colistin Performance Against Hetero- and Full-Resistant Clinical A. baumannii: A Mechanistic Study.
Journal: Antibiotics (Basel, Switzerland)
Published: March 18, 2026
Deciphering the Emergence of Biofilm-Independent Colistin Persistence and Resistance in A. baumannii: Toxin-Antitoxin Omics and Novel T/A mRNA-asRNA Balance Regulatory Models.
Journal: Antibiotics (Basel, Switzerland)
Published: February 23, 2026
Antimicrobial and Antibiofilm Activity of a Lactobacillus reuteri SGL01, Vitamin C and Acerola Probiotic Formulation Against Streptococcus mutans DSM20523.
Journal: Biomolecules
Published: December 05, 2025
Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms-Genome Proneness-Compensatory Adaptations.
Journal: Antibiotics (Basel, Switzerland)
Published: March 26, 2025
Fitness Burden for the Stepwise Acquisition of First- and Second-Line Antimicrobial Reduced-Susceptibility in High-Risk ESKAPE MRSA Superbugs.
Journal: Antibiotics (Basel, Switzerland)
Published: February 04, 2025
New Antimicrobial Resistance Strategies: An Adaptive Resistance Network Conferring Reduced Glycopeptide Susceptibility in VISA.
Journal: Antibiotics (Basel, Switzerland)
Published: March 07, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026